Videos
Cannabis Investing Newsletter
August 26, 2023
Menu
Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of August 21. Aside from presenting a synopsis of events, we provide
A new editorial paper was published in Oncoscience (Volume 10) on August 17, 2023, entitled, “Cancer drug development yesterday, today and tomorrow.”
A new study led by researchers at Karolinska Institutet in Sweden has examined how T cells of the immune system are affected by weightlessness.
Researchers at the USC Viterbi School of Engineering looked to origami to create new sensors that could someday be employed to detect deformations in organs
The non-specific lethal (NSL) complex is a chromatin-associated factor that has been shown to regulate the expression of thousands of genes in both fruit flies
The largely dormant biotech IPO market started sizzling Friday, with two Phase III drug developers sending in their pitches for Nasdaq debuts this fall. After
Baxter’s CDMO arm, BioPharma Solutions, has announced a new CEO will take the reins following its proposed sale to private equity company Advent International and
It’s been a demanding year for the pharma industry. There’s a more aggressive FTC, a changing FDA, tough market conditions, and a legal fight over
Oncopeptides’ appeal to the FDA’s withdrawal proposal for the blood cancer drug Pepaxto has been made public, shedding new light on the seesawing that’s been